No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Abiraterone Acetate
-
Adenocarcinoma / drug therapy*
-
Androgen Antagonists / administration & dosage
-
Androgen Antagonists / pharmacology
-
Androgen Antagonists / therapeutic use*
-
Androgens* / biosynthesis
-
Androstadienes / administration & dosage
-
Androstadienes / pharmacology
-
Androstadienes / therapeutic use*
-
Antineoplastic Agents, Hormonal / administration & dosage
-
Antineoplastic Agents, Hormonal / pharmacology
-
Antineoplastic Agents, Hormonal / therapeutic use*
-
Antineoplastic Agents, Phytogenic / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Clinical Trials, Phase III as Topic / statistics & numerical data*
-
Disease-Free Survival
-
Docetaxel
-
Enzyme Inhibitors / administration & dosage
-
Enzyme Inhibitors / pharmacology
-
Enzyme Inhibitors / therapeutic use
-
Humans
-
Male
-
Molecular Targeted Therapy*
-
Multicenter Studies as Topic / statistics & numerical data*
-
Neoplasm Proteins / physiology*
-
Neoplasms, Hormone-Dependent / drug therapy*
-
Prednisone / administration & dosage
-
Prostatic Neoplasms / drug therapy*
-
Randomized Controlled Trials as Topic / statistics & numerical data*
-
Receptors, Androgen / physiology*
-
Steroid 17-alpha-Hydroxylase / antagonists & inhibitors
-
Survival Rate
-
Taxoids / therapeutic use
Substances
-
Androgen Antagonists
-
Androgens
-
Androstadienes
-
Antineoplastic Agents, Hormonal
-
Antineoplastic Agents, Phytogenic
-
Enzyme Inhibitors
-
Neoplasm Proteins
-
Receptors, Androgen
-
Taxoids
-
Docetaxel
-
Steroid 17-alpha-Hydroxylase
-
Abiraterone Acetate
-
Prednisone